Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Post-Chemotherapy Cognitive Impairment With Transcranial Magnetic Stimulation (Chemobrain TMS)

NCT04295720 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT04295720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04295720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Post-Chemotherapy Cognitive Impairment With Transcranial Magnetic Stimulation (Chemobrain TMS)
Lead sponsor
University of Arizona
Phase
Not applicable
Overall status
Terminated
Start date
March 5, 2021
Completion date
March 30, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemo-brain